Our Track Record
Our IP Excellence Program has enabled over 16 companies with unique technologies that we co-founded or launched in the early-stages to develop into technology leaders with a combined aggregate market value of $26B+.
From ideas to multi-billion-dollar valuations
Acquired by Sanofi for $2.9B
Acquired by Pfizer for $14B
Idea to $1B+ public market valuation
Idea to $3.5B+ public market valuation
Idea to $1B+ public market valuation